Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
This NOFO supports scientific research that uses data from expanded access (EA) of investigational drugs or biologics for amyotrophic lateral sclerosis (ALS). The studies must focus on intermediate-size patient groups with ALS who are not eligible for ongoing ALS clinical trials, aiming to advance prevention, diagnosis, mitigation, treatment, or cure. Applications are required to use EA data s…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
-
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
Dept. of the Army -- USAMRAA
-
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Dept. of the Army -- USAMRAA
-
DoW Amyotrophic Lateral Sclerosis Research Program, Pilot Clinical Trial Award
Dept. of the Army -- USAMRAA
-
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Dept. of the Army -- USAMRAA
-
Biomedical Research Projects
Motor Neurone Disease Association
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers